Kewaunee Scientific (KEQU) Equity Average (2011 - 2026)

Kewaunee Scientific has reported Equity Average for 16 years, with the latest figure at $71.2 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 18.52% year-over-year to $71.2 million; the trailing twelve-month figure through Jan 2026 stood at $71.2 million (up 18.52% YoY), and the FY2025 full-year result was $59.6 million, up 29.35% from the prior year.
• Equity Average for Q1 2026 stood at $71.2 million, up from $68.5 million in the prior quarter.
• The five-year high for Equity Average was $71.2 million in Q1 2026, with the low at $34.5 million in Q4 2022.
• Average Equity Average over 5 years is $48.6 million, with a median of $43.1 million recorded in 2024.
• Year-over-year, Equity Average fell 13.43% in 2022 and surged 44.18% in 2024.
• Tracing KEQU's Equity Average over 5 years: stood at $34.5 million in 2022, then increased by 18.02% to $40.8 million in 2023, then jumped by 41.47% to $57.7 million in 2024, then climbed by 18.71% to $68.5 million in 2025, then grew by 3.98% to $71.2 million in 2026.
• The last three Equity Average figures came in at $71.2 million (Q1 2026), $68.5 million (Q4 2025), and $65.8 million (Q3 2025), per Business Quant data.

Peer Comparison